{"id":935134,"date":"2026-02-09T07:34:07","date_gmt":"2026-02-09T12:34:07","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/"},"modified":"2026-02-09T07:34:07","modified_gmt":"2026-02-09T12:34:07","slug":"context-therapeutics-to-participate-in-upcoming-investor-conferences-5","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/","title":{"rendered":"Context Therapeutics to Participate in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p>PHILADELPHIA, Feb.  09, 2026  (GLOBE NEWSWIRE) &#8212; Context Therapeutics Inc. (\u201cContext\u201d or the \u201cCompany\u201d) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor conferences.<\/p>\n<p>\n        <strong>Upcoming Investor Conferences<\/strong>\n      <\/p>\n<ul type=\"disc\">\n<li>Guggenheim Emerging Outlook: Biotech Summit 2026, February 11-12, 2026, New York, NY<br \/>Fireside Chat: Wednesday, February 11<sup>th<\/sup> at 8:30 AM ET<br \/>1&#215;1 Meetings on February 11<sup>th<\/sup><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>TD Cowen 46<sup>th<\/sup> Annual Health Care Conference, March 2-4, 2026, Boston, MA<br \/>Presentation: Tuesday, March 3<sup>rd<\/sup> at 10:30 AM ET*<br \/>1&#215;1 Meetings on March 3<sup>rd<\/sup><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>Citizens Life Sciences Conference, March 10-11, 2026, Miami, FL<br \/>Fireside Chat: Tuesday, March 10<sup>th<\/sup> at 11:20 AM ET<br \/>1&#215;1 Meetings on March 10<sup>th<\/sup><\/li>\n<\/ul>\n<ul type=\"disc\">\n<li>Leerink Partners Global Healthcare Conference, March 8-11, 2026, Miami, FL<br \/>Fireside Chat: Wednesday, March 11<sup>th<\/sup> at 9:20 AM ET*<br \/>1&#215;1 Meetings on March 11<sup>th<\/sup><\/li>\n<\/ul>\n<p>*A live webcast of the presentation will be available on the News and Events section of the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=R52shqMCqA-EBp2O_rGhwPsG0f2Cc6L2kC3mcG1qUBD-twMwCkOQj4EocfGgZ7vJEPvS0ZooghJ7eCjUBNguIl_lJtOS069ppkTLEMtuzm8_mKUde6hoWi-_WA4TWrh6_oBaYjmBE_sj9jw6a0Ug6I-Xwjtrxic2ExwEu9OdktexcgBOnhkUoBuFj3KYMChq\" rel=\"nofollow\" target=\"_blank\">https:\/\/ir.contexttherapeutics.com<\/a>. Replays will be available on the website for 90 days.<\/p>\n<p>For additional information or to request a meeting with members of Context\u2019s management team during these events, please contact your conference representative or <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pJ_-XhlxxPLITlU8pteoJqFCELa6ilhpFotdfUTG24F-bO-ORYuYGlm9dliVhbi7_PH3N58ATaP-ZKlR7fMyJfUvRPd4K7taTHUJmvGBgRxJh-i7ZNx6EEXxiet7KGXs\" rel=\"nofollow\" target=\"_blank\">IR@contexttherapeutics.com<\/a>.<\/p>\n<p>\n        <strong>About Context Therapeutics<\/strong><br \/>\n        <sup>\u00ae<\/sup><br \/>\n        <br \/>Context Therapeutics Inc. (Nasdaq: CNTX)\u00a0is a biopharmaceutical company advancing T cell engaging (\u201cTCE\u201d) bispecific antibodies for solid tumors. Context\u2019s goal is to build an innovative portfolio of TCE bispecific therapeutics, including CTIM-76, a Claudin 6 x CD3 TCE, CT-95, a Mesothelin x CD3 TCE, and CT-202, a Nectin-4 x CD3 TCE. Context is headquartered in Philadelphia. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=yXKDBm9nDuisiRysCrhl8nRm-ffmf4P8GKSCs-lHO4Hx9i-9CD3lgz4vHta-QBHE-xee81V7PlXv4RdT-qwT4uIl6mHRuGMdz-dGXYja7j5LwsMPX9ZA_WMDKHl3CeSG\" rel=\"nofollow\" target=\"_blank\">www.contexttherapeutics.com<\/a>\u00a0or follow the Company on\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=qgxT4M7yMxpmPgoOKkiFgiOEzwAvxNRJw-lly8SlIVnru3hdEEj8lRB5mr-6P4nU7mdrM6sf71PyR4lzEnMNEA==\" rel=\"nofollow\" target=\"_blank\">X<\/a> (formerly\u00a0Twitter)\u00a0and\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=du_VlItRgIVuesgxDR6CyPErkL4a2H97V6VgCipQ8Son7fDusmqpBQf14nU6mYwedXOqg44dLev4SKqmw3MXdcyPht0yUpgWXe3PmV_20Fny03NDjOdMDGXfeg_7ILPd\" rel=\"nofollow\" target=\"_blank\">LinkedIn<\/a>.<\/p>\n<p>\n        <strong>Forward-looking Statements<\/strong><br \/>\n        <br \/>This press release contains \u201cforward-looking statements\u201d that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. Any statements, other than statements of historical fact, included in this press release regarding strategy, future operations, prospects, plans and objectives of management, including words such as \u201cmay,\u201d \u201cwill,\u201d \u201cexpect,\u201d \u201canticipate,\u201d \u201clook forward,\u201d \u201cplan,\u201d \u201cintend,\u201d and similar expressions (as well as other words or expressions referencing future events, conditions, or circumstances) are forward-looking statements. These include, without limitation, statements regarding (i) the ability of the Company and its employees to participate in and present at conferences, (ii) the potential benefits, characteristics, safety and side effect profile of our product candidates, and (iii) the likelihood data will support future development. Forward-looking statements in this release involve substantial risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the forward-looking statements, and we therefore cannot assure you that our plans, intentions, expectations, or strategies will be attained or achieved. Other factors that may cause actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in our filings with the\u00a0U.S. Securities and Exchange Commission, including the section titled \u201cRisk Factors\u201d contained therein. Except as otherwise required by law, we disclaim any intention or obligation to update or revise any forward-looking statements, which speak only as of the date they were made, whether as a result of new information, future events, or circumstances or otherwise.<\/p>\n<p>\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Jennifer Minai-Azary<br \/>Chief Financial Officer<br \/>Context Therapeutics<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=pJ_-XhlxxPLITlU8pteoJqFCELa6ilhpFotdfUTG24EQw6MKkLAmw-ua79rtCxTNuUElL-TUPEs87SQOog07VbrJTa0ynBXvua1NHlytMtwJFjuLKI8-6aPenhlOPn2M\" rel=\"nofollow\" target=\"_blank\">IR@contexttherapeutics.com<\/a><\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ZDhkYjMxMWYtYzUwZi00Y2M2LThmZTYtMTNmNjc0YjBlN2JkLTEyMjA2NTQtMjAyNi0wMi0wOS1lbg==\/tiny\/Context-Therapeutics-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) &#8212; Context Therapeutics Inc. (\u201cContext\u201d or the \u201cCompany\u201d) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor conferences. Upcoming Investor Conferences Guggenheim Emerging Outlook: Biotech Summit 2026, February 11-12, 2026, New York, NYFireside Chat: Wednesday, February 11th at 8:30 AM ET1&#215;1 Meetings on February 11th TD Cowen 46th Annual Health Care Conference, March 2-4, 2026, Boston, MAPresentation: Tuesday, March 3rd at 10:30 AM ET*1&#215;1 Meetings on March 3rd Citizens Life Sciences Conference, March 10-11, 2026, Miami, FLFireside Chat: Tuesday, March 10th at 11:20 AM ET1&#215;1 Meetings on March 10th Leerink Partners Global Healthcare Conference, March 8-11, 2026, Miami, FLFireside Chat: &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Context Therapeutics to Participate in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-935134","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Context Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Context Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) &#8212; Context Therapeutics Inc. (\u201cContext\u201d or the \u201cCompany\u201d) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor conferences. Upcoming Investor Conferences Guggenheim Emerging Outlook: Biotech Summit 2026, February 11-12, 2026, New York, NYFireside Chat: Wednesday, February 11th at 8:30 AM ET1&#215;1 Meetings on February 11th TD Cowen 46th Annual Health Care Conference, March 2-4, 2026, Boston, MAPresentation: Tuesday, March 3rd at 10:30 AM ET*1&#215;1 Meetings on March 3rd Citizens Life Sciences Conference, March 10-11, 2026, Miami, FLFireside Chat: Tuesday, March 10th at 11:20 AM ET1&#215;1 Meetings on March 10th Leerink Partners Global Healthcare Conference, March 8-11, 2026, Miami, FLFireside Chat: &hellip; Continue reading &quot;Context Therapeutics to Participate in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-02-09T12:34:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Context Therapeutics to Participate in Upcoming Investor Conferences\",\"datePublished\":\"2026-02-09T12:34:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/\"},\"wordCount\":540,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/\",\"name\":\"Context Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=\",\"datePublished\":\"2026-02-09T12:34:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Context Therapeutics to Participate in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Context Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/","og_locale":"en_US","og_type":"article","og_title":"Context Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","og_description":"PHILADELPHIA, Feb. 09, 2026 (GLOBE NEWSWIRE) &#8212; Context Therapeutics Inc. (\u201cContext\u201d or the \u201cCompany\u201d) (Nasdaq: CNTX), a clinical-stage biopharmaceutical company advancing T cell engaging bispecific antibodies for solid tumors, today announced its participation in several upcoming investor conferences. Upcoming Investor Conferences Guggenheim Emerging Outlook: Biotech Summit 2026, February 11-12, 2026, New York, NYFireside Chat: Wednesday, February 11th at 8:30 AM ET1&#215;1 Meetings on February 11th TD Cowen 46th Annual Health Care Conference, March 2-4, 2026, Boston, MAPresentation: Tuesday, March 3rd at 10:30 AM ET*1&#215;1 Meetings on March 3rd Citizens Life Sciences Conference, March 10-11, 2026, Miami, FLFireside Chat: Tuesday, March 10th at 11:20 AM ET1&#215;1 Meetings on March 10th Leerink Partners Global Healthcare Conference, March 8-11, 2026, Miami, FLFireside Chat: &hellip; Continue reading \"Context Therapeutics to Participate in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/","og_site_name":"Market Newsdesk","article_published_time":"2026-02-09T12:34:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Context Therapeutics to Participate in Upcoming Investor Conferences","datePublished":"2026-02-09T12:34:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/"},"wordCount":540,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/","name":"Context Therapeutics to Participate in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=","datePublished":"2026-02-09T12:34:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTY1MDYxNSM3NDEzOTY3IzIyMDkxMDE="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/context-therapeutics-to-participate-in-upcoming-investor-conferences-5\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Context Therapeutics to Participate in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=935134"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/935134\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=935134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=935134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=935134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}